We would like to draw your attention to Prof. Ulrika Simonsson, who is portrayed in this short researcher profile interview. Working as a Professor of Pharmacokinetics at @Uppsala University, Ulrika is also
Pharmetheus will be at QSPC2022 – Quantitative Systems Pharmacology Conference in Leiden in April 20-22! We love to chat about MIDD vision and advancements, PBPK-QSP applications and software, career opportunities and support for
Forest plots, recommended by regulatory authorities and becoming a standard component of submission packages, can be used to efficiently summarize the impact of covariates on parameters from population models, as well as
We are glad to welcome Efosa Alohan, Analyst System Developer, to Pharmetheus. Efosa will be based in Uppsala. His experience includes system- and web development, and tech team leading in e-commerce and
Take this opportunity to book a free hybrid speed consulting session with Pharmetheus’ consultants in connection to WCoP 2022! Sign up here Pharmetheus is looking forward to World Conference on Pharmacometrics in Cape Town!
A recent publication describes a model-based population PK and exposure-response analysis for Astegolimab in Patients with severe asthma. This analysis supports the rationale for Astegolimab dosing as the highest dose tested in
The Pharmetheus team just completed its review and training on the final FDA Population Pharmacokinetics guidance, confirming that our approaches and reports are fully compliant. If you haven’t done so already, check
Pharmetheus takes an active interest in several initiatives aiming to develop software solutions to support the MIDD applications of tomorrow. Our support for Pumas AI represents one of these initiatives: Pumas-AI, Inc.